IFI-M · HBK Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-01032 // MULTI-AXIS · IFI-M

HBK Tri-Axis Dominant-Primary Series II-BL

Capsicum chinense

Habanero

Tier IIHBK Tri-Axis Dominant-Primary Series

Target Trait

1.52×

fold-change

Heat-dominant tri-axis B+K modulated fold-change

Technical Specifications

SKU

SS-F-M3-01032

Genomic Edits

8

GC Content

45.9%

Construct Length

5,022 bp

Promoter System

CaMV 35S / Ubiquitin

Expression System

Biolistic transformation

Host Strain

Particle Gun

Receptor Target

TRPV1 + TAS2R38 (suppression) + CaSR

IFI Score

152

Pathway Edits

  • TRPV1 pathway primary gene cluster for heat (IFI-H) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent HBK pathway operation
  • Cross-pathway regulatory circuit for heat-dominant HBK triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPV1, TAS2R38 (suppression), and CaSR pathways simultaneously engineeredHeat-dominant tri-axis expression strategy (HBK) with cross-pathway flux managementBiolistic co-bombardment of multi-axis transgene cassettes for high-copy integration events

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier II HBK triple-axis construct for advanced multi-modal sensory architecture combining heat, bitter-attenuation, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities